Invention Grant
- Patent Title: Homogenous suspension of immunopotentiating compounds and uses thereof
-
Application No.: US15201651Application Date: 2016-07-05
-
Publication No.: US10046048B2Publication Date: 2018-08-14
- Inventor: David Skibinksi , Siddhartha Jain , Manmohan Singh , Derek O'Hagan
- Applicant: GlaxoSmithKline Biologicals SA
- Applicant Address: BE
- Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee Address: BE
- Agent Joseph Schuller
- Main IPC: A61K39/39
- IPC: A61K39/39 ; A61K31/4745 ; A61K31/7004 ; A61K31/717 ; A61K39/095 ; A61K39/155 ; A61K31/496 ; A61K31/5377 ; A61K31/675 ; A61K31/683 ; A61K39/12 ; A61K39/00
Abstract:
The present invention generally relates to homogeneous suspensions of small molecule immune potentiators (SMIPs) that are capable of stimulating or modulating an immune response in a subject in need thereof. The homogeneous suspensions may be used in combinations with various antigens or adjuvants for vaccine therapies.
Public/Granted literature
- US20160375132A1 HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF Public/Granted day:2016-12-29
Information query
